The effects of the combination of phentolamine and vasopressin on hepatic and systemic hemodynamics in girrhotic portal hypertensive dog model

Abstract

The experimental study was aimed at elucidating the effects of phentolamine and vasopressin used separately or in combination on hepatic and systemic hemodynamics in cirrhotic portal hypertensive dogs. The results showed that either of the two drugs used separately could lead to reduction in portal venous pressure and could also influence systemic hemodynamics or lower hepatic blood flow. When phentolamine in combination with vasopressin was administered, no side-effect could be found on hepatic and systemic hemodynamics, suggesting that the drugs used in combination could efficaciously decrease portal hypertension and counteract their respective side-effect. This combination therapy will be useful in treating bleeding from esophageal variceal rupture in cirrhotic patients with portal hypertension.

Keywords

phentolamine / vasopressin / esophageal varice / liver cirrhosis / experiment

References

[1] MaddenJW, et al. . Dimethylnitrosamine induced hepatic cirrhosis:a new canine model of an ancient human disease. Surgery, 1970, 68: 260-8

[2] BoschJ, et al. . Chronic bile duct ligation in the dogs hemodynamic characterization of a portal hypertensive model. Hepatology, 1983, 3: 1002-7

[3] MaddenJJ, et al. . SkinnerDB, et al. . Effects of perfusion on the superior mesenteric artery with vasonressin. Ebert “PA: Current Topics in Surgical Research, 1970, New York, Academic Press Inc.: 81-3

[4] GroszmannBJ, et al. . Nitroglycerin improves the hemodynamic response to vasonressin in portal hypertension. Hepatology, 1984, 2: 757-62

[5] GumsonAES, et al. . A randomized trial of vasopressin and vasopressin plus nitroglycerin in the control of acute variceal hemorrhage. Hepatology, 1986, 6: 410-3

[6] GelmanS, et al. . Nitroprusside prevents adverse hemodynamic effects of vasopressin. Arch Surg, 1978, 113: 1465-8

[7] KennethR, et al. . Isoproterenol in offsetting adverse effects of vasopressin in cirrhotic patients. Am J Surger, 1975, 129: 130-6